These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26377651)

  • 1. Nano-Systems for Advanced Therapeutics and Diagnosis of Atherosclerosis.
    Gaurav C; Saurav B; Goutam R; Goyal AK
    Curr Pharm Des; 2015; 21(30):4498-508. PubMed ID: 26377651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases.
    Hu B; Boakye-Yiadom KO; Yu W; Yuan ZW; Ho W; Xu X; Zhang XQ
    Adv Healthc Mater; 2020 Aug; 9(16):e2000336. PubMed ID: 32597562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology.
    Behera SS; Pramanik K; Nayak MK
    Curr Pharm Des; 2015; 21(30):4479-97. PubMed ID: 26278923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis.
    Pang AS; Dinesh T; Pang NY; Dinesh V; Pang KY; Yong CL; Lee SJJ; Yip GW; Bay BH; Srinivasan DK
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine in the Diagnosis and Treatment of Atherosclerosis-A Systematic Review.
    Vaidyanathan K; Gopalakrishnan S
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):119-131. PubMed ID: 28925905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
    Mohamed NA; Marei I; Crovella S; Abou-Saleh H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
    Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered nanoparticles for the detection, treatment and prevention of atherosclerosis: how close are we?
    Nguyen LTH; Muktabar A; Tang J; Dravid VP; Thaxton CS; Venkatraman S; Ng KW
    Drug Discov Today; 2017 Sep; 22(9):1438-1446. PubMed ID: 28733245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle Based Treatment for Cardiovascular Diseases.
    Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
    Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine for Atherosclerosis: Molecular Imaging and Treatment.
    Karagkiozaki V; Logothetidis S; Pappa AM
    J Biomed Nanotechnol; 2015 Feb; 11(2):191-210. PubMed ID: 26349296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders.
    Maheshwari R; Tekade M; Sharma PA; Tekade RK
    Curr Pharm Des; 2015; 21(30):4427-40. PubMed ID: 26471319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis.
    Lewis DR; Kamisoglu K; York AW; Moghe PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):400-20. PubMed ID: 21523920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis.
    Ou LC; Zhong S; Ou JS; Tian JW
    Acta Pharmacol Sin; 2021 Jan; 42(1):10-17. PubMed ID: 32457416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
    Mahajan K; Bhattacharya S
    Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
    Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
    Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
    Psarros C; Lee R; Margaritis M; Antoniades C
    Maturitas; 2012 Sep; 73(1):52-60. PubMed ID: 22261366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
    Kaur M; Nagpal M; Aggarwal G
    Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Nanotechnology for Diagnosis and Drug Delivery in Atherosclerosis: A New Horizon of Treatment.
    Lankala CR; Yasir M; Ishak A; Mekhail M; Kalyankar P; Gupta K
    Curr Probl Cardiol; 2023 Jun; 48(6):101671. PubMed ID: 36828044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.